Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia

Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the development and severity of cardiovascular disease. Treatment goals may be more effectively achieved if multiple disease factors are targeted with combination treatment. We enrolled 202 patients who were random...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Jin, Xuan, Kim, Moo Hyun, Han, Ki Hoon, Hong, Soon Jun, Ahn, Jeong‐Cheon, Sung, Jung‐Hoon, Cho, Jin‐Man, Lee, Han Cheol, Choi, So‐Yeon, Lee, Kyounghoon, Kim, Woo‐Shik, Rhee, Moo‐Yong, Kim, Ju Han, Hong, Seung Pyo, Yoo, Byung Su, Cho, Eun Joo, Lee, Jae‐Hwan, Kim, Pum‐Joon, Park, Chang‐Gyu, Hyon, Min Su, Shin, Jin Ho, Lee, Sang Hyun, Sung, Ki Chul, Hwang, Jinyong, Kwon, Kihwan, Chae, In‐Ho, Seo, Jeong‐Sook, Kim, Hyungseop, Lee, Hana, Cho, Yoonhwa, Kim, Hyo‐Soo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Combination Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692919/
https://ncbi.nlm.nih.gov/pubmed/32937023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13893
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars